Sponsor Pipeline

Grey Wolf Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 1/2
2
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT06923761 EMITT-1 (ERAP Mediated Immunopeptidome Targeting Trial - 1) Advanced Solid Malignancy Recruiting
NCT07047703 EAST-1 (ERAP-inhibition in Axial Spondyloarthritis Trial - 1) Axial Spondyloarthritis (AxSpA) Recruiting
Disease Areas
Ankylosing Spondylitis (1)
Get alerts when Grey Wolf Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free